Merck to acquire Verona Pharma for $10 billion
U.S. pharmaceutical giant Merck announced Wednesday it will acquire U.K.-based Verona Pharma in a deal valued at approximately $10 billion, as the company seeks to bolster its respiratory treatment offerings and reduce dependence on its blockbuster cancer drug Keytruda. Under…